Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Canon Medical Systems Corporation, headquartered in Japan, is a prominent player in the medical, precision, and optical instruments industry. Founded in 2003, the company has established itself as a leader in medical imaging and healthcare solutions, with a strong presence in regions such as North America, Europe, and Asia.
Specialising in advanced imaging technologies, Canon Medical offers a diverse range of products, including CT, MRI, and ultrasound systems. Their commitment to innovation is evident in their unique approach to imaging, which focuses on enhancing patient care and operational efficiency.
With a reputation for quality and reliability, Canon Medical has achieved significant milestones, including numerous awards for its cutting-edge technology. As a subsidiary of Canon Inc., the company continues to strengthen its market position, driving advancements in medical imaging and contributing to improved healthcare outcomes worldwide.
+16 vs industry average
Canon Medical Systems Corporation’s score of 48 is higher than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medical Device Manufacturing has above-average carbon intensity
The Medical Device Manufacturing industry has reduced its overall emissions by 32% since 2018
Scope 3 accounts for ••• of total emissions.
Canon Medical Systems Corporation, headquartered in JP and operating in the Medical, precision and optical instruments, watches and clocks industry, reported total gross emissions of approximately 977,000 kg CO2e in 2023. This included approximately 633,000 kg CO2e from Scope 1 emissions, about 344,000 kg CO2e from Scope 2 emissions, and roughly 156,000 kg CO2e from Scope 3 emissions. Notably, Scope 3 emissions included approximately 156,000 kg CO2e from business travel, 46,000 kg CO2e from employee commute, 810 kg CO2e from purchased goods and services, 43,000 kg CO2e from upstream transportation and distribution, and 98,000 kg CO2e from downstream transportation and distribution.
The company has set a near-term target to decrease its Scope 1 and Scope 2 emissions by 42% from 2022 levels by 2030. Additionally, Canon Medical Systems Corporation has a long-term net-zero commitment, aiming to achieve Net Zero across all scopes by 2045. Emissions data and reduction targets are reported by Canon Medical Systems Corporation itself, although SBTi targets are cascaded from its ultimate parent, Canon Inc.
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
See all scope 3 categories
Already have an account? Sign in now


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more